Biotechnology
Biotechnology company to invest $1.5 billion in Illinois plasma-processing plan - The Breeze-Courier
The promises and challenges of neoantigen cancer vaccines - Nature
Biotechnology spinout Cytotrait secures £3M seed funding to address global food security and sustainable agriculture - The University of Manchester
Synthetic membraneless organelles for biotechnology applications reviewed - Nanowerk
Roche breast cancer drug falls short of expectations (for now) - European Biotechnology Magazine
AI in Biotechnology Market Size, Share, Growth | CAGR of 19.3% - Market.us Media
Giving circular value to one of the toughest waste streams with biotechnology - Circular Online
LIXTE Biotechnology (LIXT) Advances Lead Compound in Tumor Immunogenicity Research - NewMediaWire
Biotechnology company to invest $1.5 billion in Illinois plasma-processing plan - Capitol News Illinois
National Conference on Biotechnology & Forensic Science held at GIS - lokmattimes.com
Roche’s Gazyva posts strong Phase III lupus data - The Pharma Letter
Biotechnology Market Outlook 2026-2033: Size, Demand Surge, - openPR.com
Rapport Therapeutics and Tenacia Biotechnology Announce - GlobeNewswire
Turning biotechnology into hope for farmers - Bangkok Post
Why Vir Biotechnology (VIR) Is Up 5.1% After Astellas Cancer Deal And Equity Raise News - simplywall.st